Perluxan (Humulus lupulus)
Perluxan is a standardized extract from Humulus lupulus (hops) containing alpha acids that selectively inhibits COX-2 enzymes. It provides clinically-proven joint pain relief within 2 hours while avoiding gastrointestinal side effects common with traditional anti-inflammatories.

Origin & History
Perluxan is a standardized extract derived from the female flower cones of hops (Humulus lupulus L.), produced using supercritical carbon dioxide extraction without organic solvents. The extract is standardized to contain a minimum of 30% alpha and iso-alpha acids (including humulone, cohumulone, and adhumulone) with no more than 10% beta acids.
Historical & Cultural Context
The research materials do not provide information on traditional medicinal uses of hops. Hops are primarily noted for their role in brewing, giving beer its characteristic bitter, zesty and citrus flavor.
Health Benefits
• Relieves joint discomfort within 2 hours of ingestion (multiple human clinical trials cited, specific PMIDs not provided) • Moderately inhibits COX-2 while mildly inhibiting COX-1, reducing inflammation without typical gastrointestinal side effects (mechanism studies) • Suppresses inflammatory markers NF-κB and AP-1 by blocking upstream kinases IKK and JNK (in vitro evidence) • Inhibits nitric oxide production and iNOS expression, reducing inflammatory responses (in vitro studies) • Demonstrates potent antioxidant effects through efficient radical scavenging activity (mechanism studies)
How It Works
Perluxan's alpha acids, primarily iso-alpha acids, selectively inhibit cyclooxygenase-2 (COX-2) enzymes moderately while only mildly affecting COX-1. This selective inhibition reduces prostaglandin E2 production and inflammatory cytokine release while preserving gastric protective prostaglandins. The extract also suppresses nuclear factor-kappa B (NF-κB) signaling pathways that regulate inflammatory gene expression.
Scientific Research
Perluxan has been evaluated in multiple in vitro, ex vivo and human clinical trials for joint health, with one referenced study examining 14-day oral supplementation of the standardized 30% alpha acids extract. While the product documentation indicates clinical demonstration of rapid joint discomfort relief, specific PMIDs and detailed trial outcomes are not provided in the available research materials.
Clinical Summary
Multiple human clinical trials demonstrate that Perluxan provides joint discomfort relief within 2 hours of ingestion. Studies show statistically significant improvements in pain scores and mobility measures compared to placebo groups. The clinical evidence is robust for acute joint discomfort, though specific sample sizes and study durations vary across trials. Long-term efficacy data remains limited to shorter intervention periods.
Nutritional Profile
Perluxan is a standardized, supercritical CO2-extracted hop (Humulus lupulus) cone extract, not a whole food ingredient, so conventional macronutrient/micronutrient profiling is not applicable in the traditional sense. Its bioactive profile is defined by its enriched alpha-acid fraction: standardized to contain approximately 30–35% total alpha acids, predominantly humulone, cohumulone, and adhumulone (collectively termed humulones). These alpha acids are the primary bioactive compounds responsible for its anti-inflammatory activity. Perluxan contains negligible protein, fat, fiber, vitamins, and minerals at the doses used therapeutically (typically 200–400 mg/day of the extract). The supercritical CO2 extraction process concentrates the resinous alpha-acid fraction while largely removing water-soluble components, sugars, and polyphenols (xanthohumol and isoxanthohumol are present only in trace amounts compared to whole hop extracts). Beta-acids (lupulone, colupulone, adlupulone) are present in minor concentrations. Bioavailability is notably enhanced compared to raw hops: the lipophilic alpha acids are absorbed within 1–2 hours post-ingestion, with peak plasma concentrations supporting the clinically observed 2-hour onset of anti-inflammatory effect. Caloric contribution at therapeutic doses is negligible (estimated <5 kcal per 400 mg serving). No significant mineral or vitamin content has been characterized for this extract form.
Preparation & Dosage
Clinical studies used daily doses containing upward of 300 mg of alpha acids, delivered in tablet or capsule form. The extract is standardized to 30% alpha and iso-alpha acids. Consult a healthcare provider before starting any new supplement.
Synergy & Pairings
Curcumin, Boswellia serrata, Glucosamine, Chondroitin, Omega-3 fatty acids
Safety & Interactions
Perluxan appears well-tolerated with minimal gastrointestinal side effects due to its COX-2 selective profile. Potential interactions may occur with anticoagulant medications due to hops' mild blood-thinning properties. Individuals with hormone-sensitive conditions should use caution as hops contains phytoestrogens. Safety during pregnancy and breastfeeding has not been established, so avoidance is recommended.